# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Public Health Laboratory Biomonitoring Implementation Program, Program Announcement #03034
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:
*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Public Health Laboratory Biomonitoring Implementation Program, Program Announcement #03034.
*Times and Dates:* 8:30 a.m.-9:15 a.m., July 28, 2003 (Open), 9:15 a.m.-4:30 p.m., July 28, 2003 (Closed).
*Place:* J.W. Marriott, 3300 Lenox Road, NE., Atlanta, GA 30326, Telephone 404.262.3344.
*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement #03034.
For Further Information Contact: Drue Barrett, Ph.D., Deputy Associate Director for Science, National Center for Environmental Health, CDC, 4770 Buford Highway, MS-F29, Atlanta, GA 30341, Telephone 770.488.7653.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry.
Dated: June 26, 2003.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).